Clinical and metabolic parameters, Ca2+, parathormone depending on serum 25(OH)D concentration in hypertensive patients in the West-Ukrainian population
DOI:
https://doi.org/10.12775/JEHS.2021.11.12.010Keywords
25(OH)D, essential arterial hypertension, сlinical parameters, metabolic parameters, Ca2, parathormoneAbstract
Introduction. Low plasma levels of 25-OH vitamin D (25(OH)D) have been associated with an increased prevalence of hypertension. The purpose of the research was to establish the association of clinical and metabolic parameters, Ca2+, parathormone and serum 25(OH)D concentration in hypertensive patients in the West-Ukrainian population. Material and method. 100 subjects with essential arterial hypertension (EAH) and target-organ damaging (2nd stage), moderate, high, very high cardiovascular risk were involved in the case-control study. Among them, 70,84% females, 29,16% males, mean age 57,86±7,81 yo. The control group consisted of 60 healthy individuals. All recruited patients were examined for heart rate, systolic and diastolic blood pressure (SBP, DBP); SCORE, BMI, waist and hip circumference (WC, HC); lipid panel, serum glucose and ionized calcium, 25(OH)D, parathormone levels were studied. Patients were divided into groups depending on total serum 25(OH)D concentration. Results. Low 25(OH)D concentration (<30 ng/ml) in patients with EAH was associated with arrhythmia, headache, sleep disturbance, weakness, fatigue, and increased total 10-year risk for fatal CVD SCORE>5,0%. We found higher SBP and DBP by 9,12% (р=0,014) and 5,17% (р=0,047), higher BMI in men and women – by 20-28,11% (р<0,05), as well as higher values of WC and HC by 8,69-11,92% (р<0,05) in hypertensive patients with hypovitaminosis D. In addition, obesity (BMI≥30,0 kg/m2), hyperglycemia, hypertriglyceridemia was more frequent – by 43% (p<0,05), 43,13% (p<0,001) and 59,37% (p=0,023), respectively. The level of ionized Ca2+ was slightly higher in healthy individuals (p=0,047) with low vitamin D concentration. PTH was compensatory increased by 31,85% (p=0,048) in hypertensive patients with hypovitaminosis D.
Conclussions. Hypovitaminosis D is associated with more severe metabolic, hemodynamic disorders and clinical symptoms in hypertensive patients in the West-Ukrainian population.
References
References
Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS. Cardiovascular disease in the developing world: Prevalences, patterns, and the potential of early disease detection. Journal of the American College of Cardiology. 2012;60(14):1207-1216. DOI: 10.1016/j.jacc.2012.03.074
Murni I.K., Sulistyoningrum D.C., Oktaria V. Association of vitamin D deficiency with cardiovascular disease risk in children: Implications for the Asia Pacific Region. Asia Pac. J. Clin. Nutr. 2016;25:S8–S19. doi: 10.6133/apjcn.122016.s1.
Nigwekar S.U., Thadhani R. Vitamin D receptor activation: Cardiovascular and renal implications. Kidney Int. Suppl. 2013;3:427–430. doi: 10.1038/kisup.2013.89.
Almirall J., Vaqueiro M., Bare M.L., Anton E. Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrol. Dial. Transplant. 2010;25:503–509. doi: 10.1093/ndt/gfp470.
Gu J.W., Liu J.H., Xiao H.N., Yang Y.F., Dong W.J., Zhang Q.B., Liu L., He C.S., Wu B.H. Relationship between plasma levels of 25-hydroxyvitamin D and arterial stiffness in elderly Chinese with non-dipper hypertension: An observational study. Medicine. 2020;99:e19200. doi: 10.1097/MD.0000000000019200.
Qi D., Nie X.L., Wu S.L., Cai J. Vitamin D and hypertension: Prospective study and meta-analysis. PLoS ONE. 2017;12:e0174298. doi: 10.1371/journal.pone.0174298.
Jeong HY, Park KM, Lee MJ, Yang DH, Kim SH, Lee SY. Vitamin D and hypertension. Electrolyte Blood Press. 2017;15:1–11. doi: 10.5049/EBP.2017.15.1.1.
Bryan, W., Mancia, G., Spiering, W., Agabiti, R.E., Azizi, M., Burnier, M., Clement, D.L. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal 2018; 39: 3021-3104, https://doi.org/10.1093/eurheartj/ehy339.
Nakaz MOZ Ukrayiny vid 24.05.2012 №384 "Pro zatverdzhennya ta vprova-dzhennya medyko-tekhnolohichnykh dokumentiv zi standartyzatsiyi medychnoyi dopomo-hy pry arterialʹniy hipertenziyi". Nastanova ta klinichnyy protokol nadannya medychnoyi dopomohy "Arterialʹna hipertenziya". Robocha hrupa z arterialʹnoyi hipertenziyi Ukrayinsʹkoyi asotsiatsiyi kardiolohiv. Kyyiv:MOZ; 2012. 108[1].
Semianiv M, Sydorchuk L, Fedonyuk L, Nebesna Z, Kamyshnyi O, Sydorchuk A, Vasiuk V, Dzhuryak V, Semianiv I, Sydorchuk R. Metabolic and hormonal prognostic markers of essential arterial hypertension considering the genes polymorphism AGTR1 (rs5186) and VDR (rs2228570). RJDNMD [Internet]. 31Oct.2021 [cited 16Nov.2021];28(3):284-91.
Repchuk Y, Sydorchuk LP, Sydorchuk AR, et al. Linkage of blood pressure, obesity and diabetes mellitus with angiotensinogen gene (AGT 704T>C/rs699) polymorphism in hypertensive patients. Bratisl Lek Listy. 2021;122(10):715-720. doi:10.4149/BLL_2021_114.
Dzhuryak V, Sydorchuk L, Sydorchuk A, et al. The cytochrome 11B2 aldosterone synthase gene CYP11B2 (RS1799998) polymorphism associates with chronic kidney disease in hypertensive patients. Biointerface Research in Applied Chemistry 2020;10(3):5406-5411. doi:10.33263/BRIAC103.406411.
Sydorchuk LP, Dzhuryak VS, Sydorchuk AR, et al. Association of lipids' metabolism disorders with aldosterone synthase CYP11B2 (-344C/T) gene polymorphism in hypertensive patients depending on glomerular filtration rate. PharmacologyOnLine. 2020;2:230-242 https://pharmacologyonline.silae.it/files/archives/2020/vol2/PhOL_2020_2_A023_Sydorchuk.pdf
Semianiv MM, Sydorchuk LP, Dzhuryak VS et al. Association of AGTR1 (rs5186), VDR (rs2228570) genes polymorphism with blood pressure elevation in patients with essential hypertension in Ukrainian population. J Med Life. 2021;14(4): November - December, in press.
Sem'yaniv M.M. Faktory ryzyku ta polimorfizm hena AGTR1 (1166A>C) u khvorykh na esentsialʹnu hipertenziyu. Bukovynsʹkyy medychnyy visnyk. T.24, № 4 (96). pp. 99-104. https://doi.org/10.24061/2413-0737.XXIV.4.96.2020.109
Barzegari M, Sarbakhsh P, Mobasseri M, et al. The effects of vitamin D supplementation on lipid profiles and oxidative indices among diabetic nephropathy patients with marginal vitamin D status. Diabetes Metab. Syndr 2019;13:542-547. https://doi.org/10.1016/j.dsx.2018.11.008
Tao S, Yuan Q, Mao L, Chen FL, Ji F, Cui ZH. Vitamin D deficiency causes insulin resistance by provoking oxidative stress in hepatocytes. Oncotarget 2017;8(40):67605-67613. doi: 10.18632/oncotarget.18754.
Szymczak-Pajor I, Drzewoski J, Sliwi´nska A. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci 2020;21:6644. doi:10.3390/ijms21186644
Wenclewska S, Szymczak-Pajor I, Drzewoski J, Bunk M, Śliwińska A. Vitamin D Supplementation Reduces Both Oxidative DNA Damage and Insulin Resistance in the Elderly with Metabolic Disorders. Int J Mol Sci 2019;20(12):2891. doi: 10.3390/ijms20122891.
Lerchbaum E, Trummer C, Theiler-Schwetz V, et al. Effects of Vitamin D Supplementation on Body Composition and Metabolic Risk Factors in Men: A Randomized Controlled Trial. Nutrients 2019; 11:1894. https://doi.org/10.3390/nu11081894
Forouhi NG, Menon RK, Sharp SJ, et al. Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: Results of a randomized double-blind placebo-controlled trial. Diabetes Obes Metab 2016;18:392-400. https://doi.org/10.1111/dom.12625
Heshmat R, Tabatabaei-Malazy O, Abbaszadeh-Ahranjani S, et al. Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial. DARU J Pharm Sci 2012; 20: 10. https://doi.org/10.1186/2008-2231-20-10
Yiu Y-F, Yiu K-H, Siu C-W, et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013;227:140-146.DOI: 10.1016/j.atherosclerosis.2012.12.013
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Marianna Semianiv, Larysa Sydorchuk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 524
Number of citations: 0